share_log

Truist Securities Maintains Buy on Affimed, Lowers Price Target to $6

Truist Securities Maintains Buy on Affimed, Lowers Price Target to $6

Truist Securities维持对Affimed的买入,将目标股价下调至6美元
Benzinga ·  2023/08/11 10:09

Truist Securities analyst Srikripa Devarakonda maintains Affimed (NASDAQ:AFMD) with a Buy and lowers the price target from $8 to $6.

Truist证券分析师Srikripa Devarakonda维持Affimed(纳斯达克:AFMD)的买入,并将目标价从8美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发